We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORKA
4876
Oruka Therapeutics
ORKA
$6.31B
$5.14K ﹤0.01%
252
-56
-18% -$1.26K
SNGX icon
4877
Soligenix
SNGX
$5.73M
$5.13K ﹤0.01%
423
-8
-2% -$70
EBON icon
4878
Ebang International Holdings
EBON
$13.2M
$5.13K ﹤0.01%
335
+250
+294% +$2.04K
GROM
4879
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
$5.11K ﹤0.01%
4,522
+4,515
+64,500% +$5.51K
PXMD
4880
DELISTED
PaxMedica, Inc. Common Stock
PXMD
$5.11K ﹤0.01%
6,747
+6,283
+1,354% +$14.6K
BDL icon
4881
Flanigan's Enterprises
BDL
$77.3M
$5.09K ﹤0.01%
198
-139
-41% -$3.82K
BANL icon
4882
CBL International Ltd
BANL
$8.72M
$5.09K ﹤0.01%
266
-744
-74% -$13.8K
TSHA icon
4883
Taysha Gene Therapies
TSHA
$1.92B
$5.08K ﹤0.01%
+2,871
New +$5.72K
RMTI icon
4884
Rockwell Medical
RMTI
$27.9M
$5.08K ﹤0.01%
+269
New +$5.05K
MDIA icon
4885
Mediaco Holding
MDIA
$78.3M
$5.08K ﹤0.01%
11,807
+102
+0.9% +$61
E icon
4886
ENI
E
$80.3B
$5.07K ﹤0.01%
149
-2,587
-95% -$84.1K
SMFL
4887
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$5.06K ﹤0.01%
+438
New +$5.34K
CNSP icon
4888
CNS Pharmaceuticals
CNSP
$8.04M
– –
0
– –
GTBP icon
4889
GT Biopharma
GTBP
$11.3M
$5.04K ﹤0.01%
659
-13
-2% -$95
LUMO
4890
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$5K ﹤0.01%
1,574
-358
-19% -$1.22K
LTRN icon
4891
Lantern Pharma
LTRN
$35.5M
$4.98K ﹤0.01%
1,164
-693
-37% -$2.44K
BCLI
4892
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$4.98K ﹤0.01%
1,216
-1,386
-53% -$4.15K
MXC icon
4893
Mexco Energy
MXC
$19.4M
$4.98K ﹤0.01%
545
-157
-22% -$1.78K
NXU
4894
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$4.97K ﹤0.01%
108
+103
+2,060% +$14.5K
PNBK icon
4895
Patriot National Bancorp
PNBK
$136M
$4.96K ﹤0.01%
1,295
+56
+5% +$303
SURG icon
4896
SurgePays
SURG
$7.57M
$4.95K ﹤0.01%
768
-399
-34% -$2.12K
IXG icon
4897
iShares Global Financials ETF
IXG
$696M
$4.95K ﹤0.01%
63
-6
-9% -$438
AMJ
4898
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$4.95K ﹤0.01%
195
+193
+9,650% +$4.85K
STRR
4899
Star Equity Holdings
STRR
$41.3M
$4.94K ﹤0.01%
319
-433
-58% -$7.12K
FRD icon
4900
Friedman Industries
FRD
$309M
$4.92K ﹤0.01%
318
-1,246
-80% -$15.4K
194 195
196
197 198

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.